Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1990 2
1991 3
1992 1
1993 4
1994 7
1995 3
1996 8
1997 2
1998 9
1999 7
2000 4
2001 4
2002 9
2003 5
2004 9
2005 9
2006 8
2007 12
2008 12
2009 18
2010 15
2011 23
2012 15
2013 5
2014 1
2015 5
2016 7
2017 1
2018 1
2019 5
2020 9
2021 6
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, Dutta AK, Savell A, Varmeh S, Heilpern-Mallory D, Ujwary S, Zavidij O, Aguet F, Su NK, Lightbody ED, Bustoros M, Tahri S, Mouhieddine TH, Wu T, Flechon L, Anand S, Rosenblatt JM, Zonder J, Vredenburgh JJ, Boruchov A, Bhutani M, Usmani SZ, Matous J, Yee AJ, Jakubowiak A, Laubach J, Manier S, Nadeem O, Richardson P, Badros AZ, Mateos MV, Trippa L, Getz G, Ghobrial IM. Sklavenitis-Pistofidis R, et al. Among authors: vredenburgh jj. Cancer Cell. 2022 Nov 14;40(11):1358-1373.e8. doi: 10.1016/j.ccell.2022.10.017. Cancer Cell. 2022. PMID: 36379208 Free PMC article.
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: vredenburgh j. J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720927 Corrected and republished. Clinical Trial.
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: vredenburgh j. J Clin Oncol. 2023 Nov 10;41(32):4945-4952. doi: 10.1200/JCO.22.02772. J Clin Oncol. 2023. PMID: 37935104
Primary meningeal rhabdomyosarcoma.
Palta M, Riedel RF, Vredenburgh JJ, Cummings TJ, Green S, Chang Z, Kirkpatrick JP. Palta M, et al. Among authors: vredenburgh jj. Sarcoma. 2011;2011:312802. doi: 10.1155/2011/312802. Epub 2011 Jun 23. Sarcoma. 2011. PMID: 21772793 Free PMC article.
Chordoma: A Case Report and Review of Literature.
Noor A, Bindal P, Ramirez M, Vredenburgh J. Noor A, et al. Among authors: vredenburgh j. Am J Case Rep. 2020 Jan 23;21:e918927. doi: 10.12659/AJCR.918927. Am J Case Rep. 2020. PMID: 31969553 Free PMC article. Review.
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.
Reardon DA, Turner S, Peters KB, Desjardins A, Gururangan S, Sampson JH, McLendon RE, Herndon JE 2nd, Jones LW, Kirkpatrick JP, Friedman AH, Vredenburgh JJ, Bigner DD, Friedman HS. Reardon DA, et al. Among authors: vredenburgh jj. J Natl Compr Canc Netw. 2011 Apr;9(4):414-27. doi: 10.6004/jnccn.2011.0038. J Natl Compr Canc Netw. 2011. PMID: 21464146 Free PMC article. Review.
Molecularly targeted therapy for malignant glioma.
Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Sathornsumetee S, et al. Among authors: vredenburgh jj. Cancer. 2007 Jul 1;110(1):13-24. doi: 10.1002/cncr.22741. Cancer. 2007. PMID: 17520692 Free article. Review.
210 results